South Korea offers ultra-modern ovarian cancer treatments including robotic-assisted debulking surgery and Hyperthermic Intraperitoneal Chemotherapy. Leading Seoul centers integrate genomic profiling to prescribe targeted PARP inhibitors and heavy ion therapy. Specialized oncology teams utilize the Da Vinci system to improve precision and accelerate recovery.
- Robotic surgery: Da Vinci systems allow precise tumor removal through minimal incisions.
- HIPEC protocol: Heated chemotherapy is applied during surgery to eliminate microscopic cancer cells.
- Heavy ion therapy: Carbon ion beams treat resistant tumors at Severance Hospital center.
- Targeted therapy: PARP inhibitors like Olaparib treat BRCA-positive cases following genetic testing.
- Immunotherapy trials: Major academic hospitals provide access to CAR-T and checkpoint inhibitor trials.
Bookimed Expert Insight: South Korea is a global leader in surgical technology, with Severance Hospital alone hosting over 2,000 specialist doctors. While many countries focus solely on chemotherapy, Korean centers like Korea University Anam Hospital pioneered robotic reconstructions. This heavy emphasis on robotic precision often results in significantly shorter hospital stays than traditional open-abdominal surgeries.
Patient Consensus: Patients emphasize the importance of early genetic testing in Korea to qualify for advanced clinical trials and PARP inhibitors. Many note that robotic debulking allowed them to return to work within four weeks and suggest using coordinators for English support.